Polar Capital Holdings’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,540
Closed -$192K 319
2024
Q3
$192K Hold
10,540
﹤0.01% 284
2024
Q2
$183K Buy
+10,540
New +$187K ﹤0.01% 268
2024
Q1
Sell
-9,838
Closed -$227K 301
2023
Q4
$227K Sell
9,838
-10,904
-53% -$244K ﹤0.01% 267
2023
Q3
$477K Sell
20,742
-7,933
-28% -$202K ﹤0.01% 267
2023
Q2
$749K Buy
28,675
+2,910
+11% +$76.9K ﹤0.01% 267
2023
Q1
$711K Hold
25,765
﹤0.01% 272
2022
Q4
$585K Buy
25,765
+6,635
+35% +$185K ﹤0.01% 285
2022
Q3
$652 Buy
19,130
+4,600
+32% +$170K ﹤0.01% 323
2022
Q2
$423 Buy
+14,530
New +$369K ﹤0.01% 353

Other funds holding PRVA

Polar Capital Holdings's PRVA Position: Q4 2024 in Review

Polar Capital Holdings sold out of Privia Health (PRVA) in Q4 2024, closing a stake of 10,540 shares — an estimated $192K sold.

Polar Capital Holdings first reported a position in PRVA in Q2 2022 and held it in 9 quarters. The position peaked at $749K in Q2 2023. 231 funds tracked by Wall St. Rank hold PRVA as of Q4 2024.

  • Polar Capital Holdings reported no remaining Privia Health position as of Q4 2024 after selling out during the quarter.
  • Polar Capital Holdings sold 10,540 Privia Health shares in Q4 2024, an estimated $192K.
  • Polar Capital Holdings first reported a position in Privia Health in Q2 2022 and held it in 9 quarters.
  • Polar Capital Holdings's Privia Health position peaked at $749K in Q2 2023.
  • 231 funds tracked by Wall St. Rank held Privia Health as of Q4 2024.

Based on Polar Capital Holdings's 13F filing for Q4 2024, filed 14 Feb 2025.